IFNG and neoplasm: Systemic IFN-γ levels were significantly higher in CT26/HER2 tumor-bearing mice than in 4T1.2/HER2 tumor-bearing mice, despite their different tumor and spleen sizes while no CT26/HER2 tumor regression was observed in IFN-γ knockout mice